Pacific Biosciences of California Inc.

PACB | NASDAQ

$1.36

-$0.01 (-0.73%)

At close: Sep 21, 2026, 4:00 PM ET

$1.35

-$0.01 (-0.74%)

Pre-market: Sep 22, 2026, 8:48 AM ET

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	160.01M	154.01M	200.52M	128.3M	130.51M	78.89M
Cost of Revenue	109.33M	116.73M	147.74M	79.27M	71.65M	46.33M
Gross Profit	50.67M	37.28M	52.78M	49.04M	58.86M	32.57M
Operating Income	-557.56M	-474.31M	-334.47M	-307.2M	-210.44M	-104.39M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-546.06M	-309.54M	-318.16M	-314.25M	-274.87M	29.4M
Net Income	-546.38M	-309.85M	-306.74M	-314.25M	-181.22M	29.4M
Selling & General & Admin	141.49M	175.02M	169.82M	160.85M	124.12M	72.8M
Research & Development	97.31M	134.92M	187.17M	193M	112.9M	64.15M
Other Expenses	369.44M	201.66M	30.26M	2.38M	32.27M	n/a
Operating Expenses	608.24M	511.6M	387.25M	356.23M	269.3M	136.95M
Interest Expense	6.95M	13.41M	14.34M	14.69M	12.53M	267K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	717.57M	628.33M	534.99M	435.5M	340.95M	183.28M
Income Tax Expense	318K	316K	-11.42M	n/a	-93.65M	n/a
Shares Outstanding (Basic)	299.96M	274.49M	253.63M	224.55M	203.62M	165.19M
Shares Outstanding (Diluted)	299.96M	288.37M	253.63M	224.55M	204.14M	174.97M
EPS (Basic)	-1.82	-1.13	-1.21	-1.40	-0.89	0.18
EPS (Diluted)	-1.82	-1.07	-1.21	-1.40	-0.89	0.17
EBITDA	-34.2M	-242.77M	-271.13M	-282.24M	-250.76M	38.97M
EBIT	-539.1M	-296.12M	-303.82M	-299.56M	-262.34M	29.67M
Depreciation & Amortization	504.91M	53.35M	32.69M	17.32M	11.59M	9.3M